Innovative Translational Research Platform
WuXi Biology provides a full-range of in vivo and in vitro non-clinical pharmacodynamics evaluation programs and immune profile screening services.
Overview of our Facilities
- 50,000 square foot facilities:
- a Translational Research Center of Large Animal for Innovative Medicine
- a Center for Bio-Medical Research & Testing
- Offering models on non-human primates (NHP), canine and swine
- AAALAC accreditation in 2022
Our Service for Translational Research
- Biomarker Research and Tissue Banker
- PBMC, FFPE, fresh frozen tissues, microbiome and other bio-specimens collected from non-human primates, canine and swine
- Comprehensive strategy for the measurement of DNA, RNA and protein biomarker as pharmacodynamics readouts.
- Animal pre-clinical pharmacodynamics models
Experience in inflammation, oncology and rare-diseases, including but not limit:
- PBMC Immune Profiling
- PDX, CDX, syngeneic tumor models
- Ex vivo / in vivo T cell activation
- LPS-induced actue inflammation
- Bioassay, Biosafety and Virus Testing
- Bio-analysis for new modalities with method development and validation;
- Mycoplasma, sterility, endotoxin and virus testing of cell lines, cell culture processes and biotherapeutics
To learn more about immune profiling, biomarker and in vitro assays, please refer to below link:
